» Articles » PMID: 25521583

Role of WNT16 in the Regulation of Periosteal Bone Formation in Female Mice

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2014 Dec 19
PMID 25521583
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we evaluated the role of WNT16 in regulating bone size, an important determinant of bone strength. Mice with targeted disruption of the Wnt16 gene exhibited a 24% reduction in tibia cross-sectional area at 12 weeks of age compared with that of littermate wild-type (WT) mice. Histomorphometric studies revealed that the periosteal bone formation rate and mineral apposition rate were reduced (P < .05) by 55% and 32%, respectively, in Wnt16 knockout (KO) vs WT mice at 12 weeks of age. In contrast, the periosteal tartrate resistant acid phosphatase-labeled surface was increased by 20% in the KO mice. Because mechanical strain is an important physiological regulator of periosteal bone formation (BF), we determined whether mechanical loading-induced periosteal BF is compromised in Wnt16 KO mice. Application of 4800-μe strain to the right tibia using a 4-point bending loading method for 2 weeks (2-Hz frequency, 36 cycles per day, 6 days/wk) produced a significant increase in cross-sectional area (11% above that of the unloaded left tibia, P < .05, n = 6) in the WT but not in the KO mice (-0.2% change). Histomorphometric analyses revealed increases in the periosteal bone formation rate and mineral apposition rate in the loaded bones of WT but not KO mice. Wnt16 KO mice showed significant (20%-70%) reductions in the expression levels of markers of canonical (β-catenin and Axin2) but not noncanonical (Nfatc1 and Tnnt2) WNT signaling in the periosteum at 5 weeks of age. Our findings suggest that WNT16 acting via canonical WNT signaling regulates mechanical strain-induced periosteal BF and bone size.

Citing Articles

A Micro-Computed Tomography-Based Simplified Approach to Measure Body Composition, Osteoporosis, and Lung Fibrosis in Mice.

Landau M, Zou B, Yang Z, Rowan B, Anbalagan M Bio Protoc. 2025; 15(4):e5207.

PMID: 40028031 PMC: 11865830. DOI: 10.21769/BioProtoc.5207.


The Role of the Periosteum in Bone Formation From Adolescence to Old Age.

Panagakis P, Zygogiannis K, Fanourgiakis I, Kalatzis D, Stathopoulos K Cureus. 2025; 17(1):e76774.

PMID: 39897255 PMC: 11786143. DOI: 10.7759/cureus.76774.


Loss of does not affect bone and lean tissue in zebrafish.

Alvarado K, Tang W, Watson C, Ahmed A, Gomez A, Donaka R JBMR Plus. 2025; 9(2):ziae159.

PMID: 39776615 PMC: 11701521. DOI: 10.1093/jbmrpl/ziae159.


Loss of does not affect bone and lean tissue in zebrafish.

Alvarado K, Tang W, Watson C, Ahmed A, Gomez A, Donaka R bioRxiv. 2024; .

PMID: 39026892 PMC: 11257572. DOI: 10.1101/2024.07.10.601974.


De Novo Assembly, Characterization, and Comparative Transcriptome Analysis of Mature Male and Female Gonads of Rabbitfish () (Bloch & Schneider, 1801).

Huang X, Huang Z, Li Q, Li W, Han C, Yang Y Animals (Basel). 2024; 14(9).

PMID: 38731350 PMC: 11083024. DOI: 10.3390/ani14091346.


References
1.
Albers J, Schulze J, Beil F, Gebauer M, Baranowsky A, Keller J . Control of bone formation by the serpentine receptor Frizzled-9. J Cell Biol. 2011; 192(6):1057-72. PMC: 3063134. DOI: 10.1083/jcb.201008012. View

2.
Chen Y, Whetstone H, Lin A, Nadesan P, Wei Q, Poon R . Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med. 2007; 4(7):e249. PMC: 1950214. DOI: 10.1371/journal.pmed.0040249. View

3.
Rossini M, Gatti D, Adami S . Involvement of WNT/β-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int. 2013; 93(2):121-32. DOI: 10.1007/s00223-013-9749-z. View

4.
Li X, Ominsky M, Niu Q, Sun N, Daugherty B, DAgostin D . Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008; 23(6):860-9. DOI: 10.1359/jbmr.080216. View

5.
Govoni K, Wergedal J, Florin L, Angel P, Baylink D, Mohan S . Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion. Endocrinology. 2007; 148(12):5706-15. PMC: 2916650. DOI: 10.1210/en.2007-0608. View